CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 814254660
- Phone
- 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CERT Other Certification
Page 2 of 3 · 55 filings